Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Proximagen partners again with Upsher-Smith in neurology

Executive Summary

Upsher-Smith Laboratories Inc. (drug candidates for skin, CNS, cardiovascular, and women's health diseases) is teaming up with UK biotech Proximagen Neuroscience PLC for the second time. Upsher has now received exclusive North American rights to Proximagen's neuronal gap junction inhibitor tonabersat.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies